Leukotriene antagonists and symptom control in chronic persistent asthma.

Leukotriene antagonists and symptom control in chronic persistent asthma.

Detalhes bibliográficos
Principais autores:	Green, R, Pavord, I
Formato:	Journal article
Idioma:	English
Publicado em:	2001

Registros relacionados

Role of Leukotriene Receptor Antagonists in Asthma
por: Chih-Hsing Hung
Publicado em: (2012-08-01)

Leukotriene Receptor Antagonists in the Treatment of Asthma: Implications for Eosinophilic Inflammation
por: Redwan Moqbel
Publicado em: (1999-01-01)

Efficacy of Leukotriene Modifiers for the Treatment of Persistent Asthma in Children
por: Duarte G. Machado
Publicado em: (2020-12-01)

Clinical Evaluation of Leukotriene Receptor Antagonists in Preventing Common Cold-like Symptoms in Bronchial Asthma Patients
por: Takahiko Horiguchi, et al.
Publicado em: (2007-01-01)

Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Paolo Montuschi
Publicado em: (2010-06-01)

ASSESSMENT OF EFFICACY OF LEUKOTRIENE RECEPTOR ANTAGONISTS IN THERAPY OF BRONCHIAL ASTHMA IN CHILDREN
por: Yu.G. Levina, et al.
Publicado em: (2009-08-01)

ASSESSMENT OF EFFICACY OF LEUKOTRIENE RECEPTOR ANTAGONISTS IN THERAPY OF BRONCHIAL ASTHMA IN CHILDREN
por: Yu.G. Levina, et al.
Publicado em: (2009-08-01)

Inhibition of Common Cold-Induced Aggravation of Childhood Asthma by Leukotriene Receptor Antagonists
por: Shigemi Yoshihara, et al.
Publicado em: (2012-01-01)

Inhaled corticosteroids and leukotriene modifiers as mono-therapy for mild persistent asthma
por: Amr Radwan, et al.
Publicado em: (2013-07-01)

Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
por: Daniel B Hawcutt, et al.
Publicado em: (2021-07-01)

Introduction of Leukotriene Receptor Antagonists in Manitoba
por: C Macie, et al.
Publicado em: (2006-01-01)

Leukotriene Receptor Antagonists and Related Compounds
por: Sally E Wenzel
Publicado em: (1999-01-01)

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
por: Erkka Valovirta, MD, PhD
Publicado em: (2012-01-01)

Delay of Onset of Symptoms of Japanese Cedar Pollinosis by Treatment with a Leukotriene Receptor Antagonist
por: Minoru Gotoh, et al.
Publicado em: (2011-01-01)

Blocking leukotrienes optimize asthma control: The BLOC survey
por: Idrees Majdy, et al.
Publicado em: (2007-01-01)

Leukotriene modifiers in the treatment of asthma in children
por: Michele Miraglia del Giudice, et al.
Publicado em: (2009-10-01)

From the Cochrane Library: Leukotriene Receptor Antagonists for Eczema
por: Lauren Marie Toledo, et al.
Publicado em: (2024-04-01)

Clinical and functional characteristics of OSA in children with comorbid asthma treated by leukotriene receptor antagonist: A descriptive study
por: Sy Duong-Quy, et al.
Publicado em: (2023-01-01)

Churg-Strauss Syndrome Development during Asthma Therapy with Leukotriene Receptor Antagonists: Just a Coincidental Association?
por: D. De Nardo, et al.
Publicado em: (2004-09-01)

Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2
por: N. G. Astafieva, et al.
Publicado em: (2024-05-01)

Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 1
por: N. G. Astafieva, et al.
Publicado em: (2024-04-01)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Gregory R. Tintinger, et al.
Publicado em: (2010-01-01)

Significance of leukotriene blockade in an allergic model of asthma
por: Amrani Yassine, et al.
Publicado em: (2000-11-01)

Effect of a leukotriene receptor antagonist pranlukast hydrate, on airway inflammation airway hyperresponsiveness in patients with moderate to severe asthma
por: Kiyoko Wada, et al.
Publicado em: (2000-01-01)

Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model
por: Mariko Ujino, et al.
Publicado em: (2017-09-01)

Retrospective Cohort Study of Leukotriene Receptor Antagonist Therapy for Preventing Upper Respiratory Infection-Induced Acute Asthma Exacerbations
por: Hiroto Matsuse M.D., Ph.D., et al.
Publicado em: (2013-09-01)

Addition of Leukotriene Receptor Antagonists to Inhaled Corticosteroids Improved QOL of Patients with Bronchial Asthma Surveyed in Suburban Tokyo, Japan
por: Nobuharu Ohshima, et al.
Publicado em: (2011-01-01)

Effect of Selective Cysteinyl Leukotriene Receptor Antagonists on Airway Inflammation and Matrix Metalloproteinase Expression in a Mouse Asthma Model
por: Chia-Hsiu Hsu, et al.
Publicado em: (2012-08-01)

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
por: Gabriele Di Lorenzo, et al.
Publicado em: (2008-12-01)

The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field
por: Eustachio Nettis, et al.
Publicado em: (2010-01-01)

Update on leukotriene receptor antagonists in preschool children wheezing disorders
por: Montella Silvia, et al.
Publicado em: (2012-06-01)

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma
por: Sasikala Kumaravel, et al.
Publicado em: (2014-01-01)

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma.
por: Barnes, N, et al.
Publicado em: (2012)

Effect of montelukast on leukotriene B4 metabolism in asthma
por: HU Yu, et al.
Publicado em: (2023-05-01)

Effect of add-on therapy with leukotriene receptor antagonists and Chungsangboha-tang in patients with asthma: a protocol for a randomized, placebo-controlled, parallel, multicenter trial
por: Sung-Woo Kang, et al.
Publicado em: (2025-02-01)

Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
por: Murat Yarıktaş, et al.
Publicado em: (2002-12-01)

Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
por: James P Kemp
Publicado em: (2009-11-01)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
por: Ludwig Aigner, et al.
Publicado em: (2020-12-01)

Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
por: A. J. Theron, et al.
Publicado em: (2014-01-01)

Effect of a leukotriene receptor antagonist on cough receptor sensitivity and allergen-induced cough in a patient with atopic cough variant asthma
por: Hideko Kobayashi, et al.
Publicado em: (1998-01-01)